multiple sclerosis

Sanofi's tolebrutinib woes pile up with FDA delay, trial miss

Sanofi's stockings may hang empty this holiday season—at least when it comes to tolebrutinib in non-relapsing secondary progressive multiple sclerosis.

Eric Sagonowsky Dec 15, 2025 9:30am

Contineum-J&J drug fails to improve vision in phase 2 MS trial

Nov 20, 2025 5:26pm

Image comparing healthy and degraded myelin sheath

Roche reports phase 3 multiple sclerosis wins for BTK inhibitor

Nov 10, 2025 6:26am

target reach ladder climb meet win beat competition

Zenas autoimmune drug prompts 95% drop in lesions in MS study

Oct 27, 2025 9:25am

Outline of human head with female symbol inside

Diabetes drug soothes brain inflammation in female mice with MS

Oct 15, 2025 6:16pm

Sanofi's troubled MS hopeful tolebrutinib hit by FDA delay

Sep 22, 2025 8:00am